Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie Gilks

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|December 2, 2005
Scaling up treatment--why we can't waitJim Yong Kim, Charlie Gilks
Bulletin of the World Health Organization|May 1, 2010
Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIVAnand A Date, Marco Vitoria, Reuben Granich, et al.
Journal of the International AIDS Society|March 9, 2010
Highly active antiretroviral treatment for the prevention of HIV transmissionReuben Granich, Siobhan Crowley, Marco Vitoria, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 11, 2008
Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and ZimbabweSylvia K Muyingo, A Sarah Walker, Andy Reid, et al.
AIDS (London, England)|July 25, 2022
Enabling timely HIV postexposure prophylaxis access in sub-Saharan AfricaAndrew N Phillips, Euphemia Sibanda, Kenly Sikwese, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|December 2, 2005
Scaling up treatment--why we can't waitJim Yong Kim, Charlie Gilks
Bulletin of the World Health Organization|May 1, 2010
Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIVAnand A Date, Marco Vitoria, Reuben Granich, et al.
Journal of the International AIDS Society|March 9, 2010
Highly active antiretroviral treatment for the prevention of HIV transmissionReuben Granich, Siobhan Crowley, Marco Vitoria, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 11, 2008
Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and ZimbabweSylvia K Muyingo, A Sarah Walker, Andy Reid, et al.
AIDS (London, England)|July 25, 2022
Enabling timely HIV postexposure prophylaxis access in sub-Saharan AfricaAndrew N Phillips, Euphemia Sibanda, Kenly Sikwese, et al.
Pageof 1